Blood glucose reduction and insulin secretion levels from the oral DehydraTECH-tirzepatide were comparable to injected Zepbound® KELOWNA, BC / ACCESSWIRE / January 14, 2025 / Lexaria Bioscience ...
contributed to our Q4 results,” said EliLilly Chair and CEO David A. Ricks. “We continued to make progress on our manufacturing build-out, and U.S. supply across all doses of tirzepatide was ...